Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04118660 · ClinicalTrials.gov registry record

Thoracic Specimen Registry

A clinical trial of Lung Cancer and Lung Transplant, sponsored by Mayo Clinic.

Recruiting
Registry status
7,000
Enrollment target
1
Study location

NCT04118660 is a study of Lung Cancer and Lung Transplant that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 7,000 participants, above the 919-participant average among 409 other Lung Cancer trials with a reported enrollment target (662% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04118660, a study of Lung Cancer and Lung Transplant, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
7,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other cancers and diseases of the thorax by developing a complete repository of specimens from patients with thoracic disease including but not limited to suspected lung cancer, mediastinal and pleural tumors, lung transplants and from patients at a very high risk of developing other thoracic cancers or other thoracic diseases.

Interventions

  • OTHER Tissue Banking

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 7,000 participants
Start Date 2017-03-01
Est. Completion 2028-01

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04118660

The ClinicalTrials.gov registry entry for NCT04118660 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 919-participant average among 409 other Lung Cancer trials with a reported enrollment target (662% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tissue Banking is the first listed.

NCT04118660 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04118660 about?

NCT04118660 is a clinical study titled "Thoracic Specimen Registry". The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other cancers and diseases of the thorax by developing a complete repository of specimens from patients with thoracic disease including but not limi...

What is the current status of trial NCT04118660?

This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2017-03-01. Estimated completion is 2028-01.

What conditions does trial NCT04118660 study?

This clinical trial studies the following conditions: Lung Cancer, Lung Transplant, Thoracic Diseases.

What interventions are being tested in trial NCT04118660?

The interventions under investigation include: Tissue Banking (OTHER).

Who is sponsoring clinical trial NCT04118660?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04118660 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.